Nurix Therapeutics is trading 4.02% up at $26.11, possibly tied to investor positioning ahead of a fireside chat.

  • It outperformed a weaker broader market on September 14, 2026; no confirmed company-specific announcement directly explains it by 12:18 p.m. EST.
  • The H.C. Wainwright 28th Annual Global Investment Conference fireside chat is scheduled for 1:00 p.m. EDT; recent focus includes Roche collaboration, pipeline progress and upcoming healthcare-conference appearances.
  • No explicit catalyst is identified; recheck after the conference.